Loading...

Tiffany Tanaka

Title(s)Assistant Clinical Professor, Medicine
SchoolHealth Sciences
Phone858-534-5875
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Reilly B, Tanaka TN, Diep D, Yeerna H, Tamayo P, Zhang K, Bejar R. DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes. Blood Adv. 2019 Oct 08; 3(19):2845-2858. PMID: 31582393.
      View in: PubMed
    2. Wang HY, Tanaka TN, Dell'Aquila M. Acute myeloid leukaemia evolving from essential thrombocythaemia with marked KMT2A amplification as a homogenously staining region. Br J Haematol. 2019 Aug; 186(4):509. PMID: 31134617.
      View in: PubMed
    3. Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A. Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update. Blood Adv. 2019 Apr 23; 3(8):1197-1210. PMID: 30971397.
      View in: PubMed
    4. Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A. Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update. J Clin Oncol. 2019 May 20; 37(15):1336-1351. PMID: 30969847.
      View in: PubMed
    5. Tanaka TN, Bejar R. MDS overlap disorders and diagnostic boundaries. Blood. 2019 Mar 07; 133(10):1086-1095. PMID: 30670443.
      View in: PubMed
    6. Medeiros BC, Tanaka TN, Balaian L, Bashey A, Guzdar A, Li H, Messer K, Ball ED. A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2018 05; 18(5):346-352.e5. PMID: 29572158.
      View in: PubMed
    7. Sallman DA, Tanaka TN, List A, Bejar R. SOHO State of the Art Update and Next Questions: Biology and Treatment of Myelodysplastic Syndromes. Clin Lymphoma Myeloma Leuk. 2017 10; 17(10):613-620. PMID: 29025689.
      View in: PubMed